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All nervous systems are subject to neuromodulation. Neuromodulators can be delivered as local hormones,
as cotransmitters in projection neurons, and through the general circulation. Because neuromodulators can
transform the intrinsic firing properties of circuit neurons and alter effective synaptic strength, neuromodu-
latory substances reconfigure neuronal circuits, often massively altering their output. Thus, the anatomical
connectome provides a minimal structure and the neuromodulatory environment constructs and specifies
the functional circuits that give rise to behavior.Introduction
Neuromodulation adds extraordinary
richness to the dynamics that networks
can display. It also adds confounds of
many kinds that require that we relinquish
our wish for simple and linear answers to
how brain circuits work. In this review,
my goal is to summarize many of the
take-home lessons from old and new
work on neuromodulation that can inform
the trajectory of future work on circuits,
large and small.
Historians say that we should study
history to avoid repeating the mistakes
of the past. Remarkable advances in
anatomical methods, genetics, optoge-
netics, and optical recordings are provid-
ing extraordinary opportunities for under-
standing circuit structure and function
in brains of all kinds. The present era
of circuit exploration is tremendously
exciting. At the same time, I see numerous
examples of today’s researchers effec-
tively ‘‘reinventing the wheel,’’ albeit ele-
gantly enough for publication in our elite
journals, partially because the new work
is done with state-of-the art techniques,
and because the pioneering work on
modulation and dynamics of small circuits
has been partially obscured by the mists
of time. Those interested in how circuit
dynamics arise from the properties of
neurons and their connections should
read Getting’s prescient 1989 review
(Getting, 1989).
Studies of some of the substances that
we now term neuromodulators have
a long and venerable history. The pharma-
cologists who worked 80 and 100 years
ago already knew that there were multiplereceptors for acetylcholine and norephi-
nephrine (Dale, 1935) and that these
were pharmacologically separable. By
the early 1970s it was already clear that
different classes of neurons released
different neurotransmitters (Barker et al.,
1972; Carraway and Leeman, 1973;
Chang and Leeman, 1970; Kerkut and
Cottrell, 1963; Kerkut and Walker, 1966;
Otsuka et al., 1967; Walker et al., 1968)
and that there were a large number of
signaling molecules used in the brains of
all animals including ACh, dopamine,
norepinephrine, GABA, glycine, gluta-
mate, serotonin, histamine, octopamine,
and neuropeptides.
Although the diversity of signaling
molecules was fascinating neurochemists
of the day, many of the earliest workers
interested in the neuronal circuits that
gave rise to behavior saw no relevance
of what they called ‘‘pharmacology’’ or
‘‘neurochemistry.’’ Instead, many of the
early circuit electrophysiologists came
from the traditions of engineering and
electronics and sought to develop a
connectivity diagram (or connectome in
today’s parlance) that would be the bio-
logical equivalent of an electronic circuit
diagram, taking advantage of the identifi-
able neurons in invertebrate sensory and
motor circuits (Burrows, 1975a, 1975b;
Calabrese and Peterson, 1983; Getting,
1981; Heitler and Burrows, 1977; Kristan
and Calabrese, 1976; Kristan et al., 1974;
Mulloney and Selverston, 1974a, 1974b;
Stent et al., 1978, 1979; Willows et al.,
1973; Wilson, 1961, 1966).
I was once told by one of the leaders in
the field that the neurotransmitter thatNeuronmediated a synaptic connection was
irrelevant, and the only thing that mat-
tered was the sign of the synapse, excit-
atory or inhibitory. Although today’s
anatomists must know that neuromodula-
tory neurons can release their cotransmit-
ters at a distance from their targets
(Blitz et al., 2008; Brezina, 2010; Jan
and Jan, 1982), the underlying assump-
tion of today’s electron microscope con-
nectome projects (Briggman et al., 2011;
Chklovskii et al., 2010; Denk et al., 2012;
Lichtman and Denk, 2011; Seung, 2011)
is that the conventional close-apposition
synapses provide most, if not all, of the
information needed to characterize the
circuit, the same assumption that was
made 35 years ago by the small-circuit
physiologists.
The Early Era of Neuromodulation
In their preface, Kaczmarek and Levitan
(1987) wrote that their book, Neuro-
modulation: The Biochemical Control of
Neuronal Excitability, was intended to
create a working understanding between
electrophysiologists and biophysicists
on the one hand and neurochemists on
the other hand to understand the modula-
tion of neuronal excitability and its conse-
quences for neural processing. By 1987 it
was clear that:
(1) Neuronal intrinsic properties, action
potential waveforms and membrane
currents could be altered by manipulating
the intracellular concentrations of second
messengers such as cAMP (DeRiemer
et al., 1985; Hockberger and Connor,
1984; Kaczmarek et al., 1986; Levitan,
1978; Siegelbaum et al., 1982).76, October 4, 2012 ª2012 Elsevier Inc. 1
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rinic agonists, amines, and neuropeptides
can increase or decrease the amplitude of
a variety of voltage-dependent currents
(Adams and Brown, 1980; Brown and
Adams, 1980; Camardo et al., 1983; Dun-
lap and Fischbach, 1981).
(3) Exogenous application of neuro-
modulators could alter the strength of
synapses (Dudel, 1965; Glusman and
Kravitz, 1982; Klein et al., 1982; Klein
and Kandel, 1978), with implications
for experience-dependent changes in
behavior (Kandel and Schwartz, 1982).
Neuromodulation Was Part of
a Paradigm Shift in the Study of
Small Circuits—The First ‘‘Beyond
the Connectome’’ Realization
By the end of the 1980s there was an
almost complete paradigm shift in the
study of small circuits for six reasons:
(1) It saw the end of the hope that similar
motor patterns found in different species
would be generated by similar circuits
(Getting, 1989). By this time, enough
was known about the specifics of
rhythmic pattern generation in different
animals to show that the details of each
circuit were different, but there were
certain canonical principles, or ‘‘building
blocks,’’ across preparations (Getting,
1989).
(2) It brought the realization that it
was going to be extremely difficult to
obtain data sufficient to constrain detailed
models of all but the simplest circuits (Sel-
verston, 1980). This remains one of the
most thorny problems in understanding
biological circuits today. Because the
output of all biological circuits results
from the interaction of many nonlinear
elements, computational models are
needed to understand them. How realistic
do these models need to be, and what
data are needed to constrain these
models? How will modulation alter these
processes?
(3) It gave us the beginnings of the
cellular mechanisms underlying neuro-
modulation of excitability (DeRiemer
et al., 1985; Dunlap and Fischbach,
1981; Kaczmarek et al., 1986; Levitan
et al., 1979).
(4) It was the beginning of the under-
standing that neuronal dynamics and
neuromodulatory mechanisms reconfig-
ure circuits so that they could no longer2 Neuron 76, October 4, 2012 ª2012 Elsevierbe viewed as ‘‘hard-wired’’ (Eisen and
Marder, 1984; Getting, 1989; Marder,
1984; Marder and Hooper, 1985), but
capable of variable outputs under modu-
lator control.
(5) It brought the realization that circu-
lating hormones and local neurohor-
mones could alter behavior by acting at
every level from sensory neuron (Pasztor
and Bush, 1987) to central circuits (Harris-
Warrick and Kravitz, 1984; Hooper and
Marder, 1984; Marder and Hooper,
1985) to neuromuscular junctions and
muscles (Lingle, 1981; Schwarz et al.,
1980). This raised the possibility that the
same modulator could act at different
sites within a circuit to keep outputs coor-
dinated, that different modulators could
compensate for changes at one site with
changes elsewhere, or that modulators
could effectively change the gain of one
portion of a circuit or process without
altering others (Brezina, 2010).
(6) It demonstrated the prevalence of
cotransmission in neurons of all kinds,
including diffuse modulatory projection
neurons that can liberate their transmitter
at some distance from receptors (Adams
and O’Shea, 1983; Bishop et al., 1987;
Jan and Jan, 1982; Kupfermann, 1991;
Nusbaum and Marder, 1989a; Siwicki
et al., 1987).
Diffuse Projections, Hormones,
and Local Hormones Determine
the Modulatory Tone of the Brain
One of the most remarkable features
of biological systems is that they are
endlessly adaptable while usually main-
taining their functional integrity. More-
over, many brain disorders, such as
schizophrenia, depression, and epilepsy,
are probably associated with some
degree of dysfunction in modulatory
control systems. Many of the other contri-
butions in this issue will deal with the
modulation of disparate regions of the
vertebrate brain by the diffuse aminergic
projections, local interneurons with
peptide cotransmitters, and peptidergic
systems that are important for pain regu-
lation and other physiological processes.
In their outstanding review in this issue,
Taghert and Nitabach (2012) describe
much of the wonderful recent work in flies
and worms describing the roles of neuro-
peptides in specific behaviors. Conse-
quently, in this review I will focus onInc.‘‘take-home messages’’ that have come
from the study of neuromodulation pri-
marily using crustacean and molluscan
systems, and I draw heavily on specific




It can be useful to distinguish between
neuromodulation that is intrinsic to the
system or circuit being considered and
modulation that is delivered from an
extrinsic source (Cropper et al., 1987;
Katz, 1995; Katz and Frost, 1996; Morgan
et al., 2000). In the former case, themodu-
latory substance is released by one of the
circuit components, while in the latter
case the modulatory substance is
released from a source not directly part
of the circuit at hand (Figure 1). In the
simplest case, a neuron that releases
a cotransmitter that alters the excitability
of its postysynaptic targets is intrinsic
(Cropper et al., 1987; Katz and Frost,
1995a, 1995b; Weiss et al., 1992, 1978),
while a neurohormone that is liberated
by a neurosecretory structure and travels
through the circulation is unambiguously
extrinsic (Christie et al., 1995). While at
some level this is an artificial distinction,
it points out that neurons can alter the
configuration of the networks with which
they are active in complex and rich ways
(Katz and Frost, 1995a, 1995b). Moreover,
if the cotransmitters liberated from the
same neuron are differentially released
as a function of the dynamics of presyn-
aptic activity (Brezina et al., 2000a; Karhu-
nen et al., 2001; Peng and Horn, 1991;
Peng and Zucker, 1993), this can alter
the extent to which these substances
influence postsynaptic function under
different conditions.
Circuits Are Multiply Modulated
Neuromodulation of circuit function has
been studied for more than 40 years in
crustaceans and mollusks. The crusta-
cean stomatogastric ganglion (STG)
contains30 neurons and the crustacean
cardiac ganglion contains only nine
neurons. Both are central pattern gener-
ating circuits that generate fictive motor
patterns when removed from the animal,
and both are modulated by a large
number of different substances (Blitz










Figure 1. Intrinsic and Extrinsic Modulation
Extrinsic modulation comes from outside the circuit or modu-
lated target. Intrinsic modulation refers to neurons that are
part of a circuit and release modulators that can alter the prop-
erties of other circuit elements. Drawing loosely after Katz and
Frost (1996).
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2011; Marder and Bucher, 2007;
Stein, 2009;Wiwatpanit et al., 2012).
Figure 2 summarizes a partial list
of what is known about the neuro-
modulatory control of the crab
STG. These data were accumulated
over the years by many laboratories
using a combination of immuno-
cytochemistry and biochemical
techniques. Most recently, mass
spectrometry has allowed the iden-
tification and characterization of
many individual members of a
number of different peptide families
(Dickinson et al., 2009; Ma et al.,
2009a, 2009b, 2009c; Stemmler
et al., 2010). Many of the same
substances are released both by
descending modulatory neurons
and by neurosecretory structures
as hormones.
It is unlikely that the STG is
unusual in the number of its modula-
tory inputs. A large number of neu-
romodulators are known to have
important functions in the Aplysia
feeding circuit (Brezina and Weiss,
1997; Furukawa et al., 2003; Koh
and Weiss, 2007; Li et al., 2001;
Proekt et al., 2005; Sweedler et al.,
2002; Vilim et al., 2010; Wu et al.,
2010), another system in which the
search for modulators has been
intense. And certainly, the number
of important peptide modulators
known in C. elegans and Drosophilais also large (Bargmann, 2012; Taghert
and Nitabach, 2012). In contrast, there
are relatively few vertebrate circuits, in
which there have been determined
attempts to find all of the modulatory
inputs to the circuit. But, whether there
are five or 12 or 25 modulators that can
influence the output of a given circuit in
the brain, no circuit is likely to be modu-
lated by only one or two substances, no
matter how tempting it is to think that
a single substance is solely responsible





The exogenous application of neuromo-
dulatory substances and the stimulation
of modulatory projection neurons cansignificantly alter circuit output (Blitz et al.,
2004, 1999, 1995, 2008; Dando and
Selverston, 1972; Dickinson et al., 2001;
Dickinson and Marder, 1989; Dickinson
et al., 1990; Dickinson and Nagy, 1983;
Eisen and Marder, 1984; Flamm and
Harris-Warrick, 1986a, 1986b; Hooper
and Marder, 1984, 1987; Nagy and Dick-
inson, 1983; Nagy et al., 1988; Nusbaum
and Marder, 1988, 1989a, 1989b; Saide-
man et al., 2006, 2007).
When the effects of descending modu-
latory projection neurons on the STG are
removed by either cutting or blocking
the input nerve to the STG, the fast pyloric
rhythm either stops completely or slows
down (Figure 3, control). Under these
conditions, exogenous application of a
large number of different substances
can elicit a triphasic motor pattern (Fig-
ure 3), although each substance producesNeuron 76, Oa different form of the rhythm. These
data were initially interpreted as
showing that the same neuronal
circuitry can be reconfigured differ-
ently by each of a large number of
neuromodulators. That interpreta-
tion still holds. But these data also
make a second point: there are
a large number of different neuro-
modulators that can activate the
network. To some extent these
constitute degenerate mechanisms
that can, as a first approximation,
substitute for each other, if it is
more important that a rhythm exist
than its exact form. This is especially
the case if the neuromuscular junc-
tions activated by these motor
neurons act as a temporal filter
(Brezina, 2010; Hooper andWeaver,
2000; Morris and Hooper, 1998).
Modulators may also stabilize motor
patterns (Zhao et al., 2011).
In addition to the fast pyloric
rhythm, the STG also expresses
two slower rhythms, the gastric mill
rhythm and the cardiac sac rhythm.
These rhythms require descending
modulatory inputs for their expres-
sion. Figure 4A shows a cartoon
comparing the effects of stimulating
three different proctolin-containing
modulatory projection neurons on
the pyloric and gastric rhythms
of the crab. While each of these
neurons contains and releases
proctolin, the cotransmitter comple-ment of these three neurons is different
(Blitz et al., 1999), and stimulation of these
neurons elicits different motor patterns
from the STG. A full gastric rhythm is
elicited by MCN1. MPN increases the
frequency of the fast pyloric rhythm, while
MCN7 activates still a different rhythm.
Not only canmodulators alter themotor
patterns produced by a single circuit, but
they can also combine elements from two
circuits into one. The schematic shown in
Figure 4B shows that the neuropeptide
Red Pigment Concentrating Hormone
(RPCH) strengthens synapses from the
IVN neurons to STG network neurons
and creates a single, conjoint rhythm
from neurons that ordinarily are part of
the cardiac sac and gastric rhythm (Dick-
inson et al., 1990). This is one of many
examples of circuit switching in the STG,
in which neurons switch from being partctober 4, 2012 ª2012 Elsevier Inc. 3
Figure 2. Partial Summary of Neuromodulation of the STG
The crab stomatogastric ganglion (STG) sits anterior to the heart within an artery that bringsmodulatory amines and peptides from neurosecretory structures such
as the pericardial organs (bottom list). Twenty-five pairs of descending modulatory neurons bring a host of substances into the neuropil of the STG (right). The
number of family members of the neuropeptides are shown in parentheses. Figure wasmade by D. Bucher, summarizing work from the Li and Stemmler labs and
numerous collaborators.
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Overviewof the pyloric or gastric circuits (Weimann
and Marder, 1994; Weimann et al., 1991).
While some aspects of the effects
of a cotransmitter-containing projection
neuron may be recapitulated with bathFigure 3. Multiple Neuromodulators Can Activ
In each panel the top two traces are intracellular reco
recording from the lateral ventricular nerve (lvn) that c
4 Neuron 76, October 4, 2012 ª2012 Elsevierapplication of one of its substances, it is
unlikely that exogenous bath applications
will reproduce the concentration profiles
that are produced by neural stimulation.
In contrast, there are substances thatate Different Forms of the Pyloric Rhythm
rdings from the lateral pyloric (LP) and pyloric dilator
arries the axons of the LP, PD, and pyloric (PY) neuro
Inc.only reach the neuropil of the STG as
circulating hormones (Saideman et al.,
2006; Weimann et al., 1997). In this
case, bath applications at realistic
concentrations are far more likely to(PD) neurons. The bottom trace is an extracellular
ns (Marder and Weimann, 1992).
Figure 4. Modulatory Reconfiguration of Circuits
(A) Three different proctolin-containing modulatory neurons each evoke different changes in STG motor patterns. (Blitz et al., 1999; Nusbaum et al., 2001).
(B) Bath application of RPCH constructs a conjoint rhythm from previously separate cardiac sac and gastric mill circuit elements. Modified from Dickinson
et al. (1990).
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One of the goals of much of the work on
the modulation of the STG has been to
determine the mechanisms that account
for the changes in circuit performance
elicited by modulators on the basis of
the modulator’s action on specific cellular
and synaptic targets (Eisen and Marder,
1984; Flamm and Harris-Warrick, 1986a,
1986b; Hooper andMarder, 1987; Marder
and Eisen, 1984a). In these experiments
pharmacological blockade of the gluta-
matergic inhibitory synapses was com-
bined with photoinactivation of specific
dye-filled neurons (Miller and Selverston,
1979) to isolate individual neurons for
study.
These studies demonstrated (1) that
electrically coupled neurons could
respond differently to the same modula-
tory substance (Marder and Eisen,
1984a), (2) that a given neuron could be
a direct target for multiple modulatory
substances (Flamm and Harris-Warrick,1986b; Hooper andMarder, 1987; Marder
and Eisen, 1984a; Swensen and Marder,
2000), (3) that multiple circuit neurons
were simultaneous targets of the same
neuromodulator (Flamm and Harris-
Warrick, 1986b; Harris-Warrick and John-
son, 2010;Hooper andMarder, 1987), and
(4) that all circuit neurons are the subject of
modulation (Harris-Warrick and Johnson,
2010; Swensen and Marder, 2001).
The effects of dopamine on membrane
currents and receptors in STG neurons
have been extensively studied (Clark and
Baro, 2006, 2007; Clark et al., 2008;
Harris-Warrick et al., 1995a, 1995b;
Harris-Warrick and Johnson, 2010; Peck
et al., 2006; Zhang et al., 2010). An unex-
pected result from this work is that dopa-
mine modulates several currents in the
same neuron and that the same current
can be modulated differently in different
target neurons (Figure 5A).
Every Synapse Is Subject to
Neuromodulation
The dynamics of circuit modulation in the
STG also involves modulation of synaptic
strength (Dickinson et al., 1990; Eisen and
Marder, 1984; Harris-Warrick and John-Neuronson, 2010; Johnson et al., 2011; Johnson
and Harris-Warrick, 1990; Kloppenburg
et al., 2000; Thirumalai et al., 2006; Zhao
et al., 2011). Figure 5B shows that the
same synapse is subject to modulation
by dopamine, serotonin, and octopamine.
Additionally, the extent of the modulation
is altered as a function of synaptic
depression (Johnson et al., 2011). This
shows that there is an interaction between
neuromodulation and other use-depen-
dent processes that also influence
synaptic strength during ongoing circuit
activity.
The Interaction between Basal
Neuromodulatory Tone and Phasic
Activation of Neuromodulatory
Inputs
Many of the same substances are deliv-
ered by specific modulatory projections
into the STG and also are released into
the hemolymph from neurosecretory
structures such as the pericardial organs
(Figure 2). This same dual function is
a general feature of many nervous
systems (Keller, 1992). The concentration
of neuromodulators in the hemolymph are
in the nanomolar range, while release76, October 4, 2012 ª2012 Elsevier Inc. 5
Figure 5. Aminergic Modulation of Pyloric Circuit Elements
(A) The actions of dopamine on ionic currents in the indicated neurons are shown. From Harris-Warrick (2011).
(B) Graded IPSPs evoked in the postsynaptic PD neuron by depolarization of the LP neuron in control (black traces), dopamine (red), octopamine (blue), and
serotonin (green). Modified from Johnson et al. (2011).
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substantially higher concentrations, at
least for short periods of time in response
to bursts of presynaptic activity (Rodgers
et al., 2011a, 2011b). Neurons in the STG
show DA receptors at nonsynaptic
regions (Oginsky et al., 2010), consistent
with their role as signaling a tonic modula-
tory tone. Moreover, tonic low concentra-
tions of DA seem to be important for
maintaining circuit basal function, while
phasic, higher concentrations produce
shorter-term modulation (Rodgers et al.,
2011a, 2011b).
How Can Highly Modulated Circuits
Be Stable in the Face of Parameter
Changes Brought about by
Modulation?
One of the most puzzling questions
arising from extensive neuromodulation
is how the integrity of the modulated
circuits is maintained, although so may
circuit parameters can be altered. If one
tries to build a computational model of
either a single neuron or a circuit, it can
be quite hard to find a set of parameters
that are consistent with the desired
output. Indeed, random assignment of
parameters to a single neuron or a circuit
will lead to significantly more failures than
successful models (Prinz, 2010; Prinz
et al., 2003a, 2004; Taylor et al., 2009).
Nonetheless, there are many different
sets of parameters that can produce
similar output patterns (Goldman et al.,
2001; Prinz et al., 2004; Taylor et al.,6 Neuron 76, October 4, 2012 ª2012 Elsevier2009). There are circumstances in which
neuromodulators are used to qualitatively
transform the behavior of a circuit, such
as during transitions from sleep to wake-
fulness (McCormick, 1989, 1992; McCor-
mick and Bal, 1997) or when a hormonal
pathway is used to trigger eclosion (Kim
et al., 2006) or molting (Webster et al.,
2012). There are also neuromodulatory
influences that reshape networks during
ongoing behavior, and the sets of param-
eters that are produced by neuromodula-
tor action must be consistent with stable
and appropriate cellular and circuit func-
tion (Goldman et al., 2001).
Understanding how circuits can be
stable in the face of ubiquitous neuromo-
dulation is an important and deep
problem. Why don’t the circuits important
for behavior become ‘‘overmodulated’’
more often, and what mechanisms might
protect against overmodulation? The
answers to this question may be partially
idiosyncratic to each circuit, but I suggest
some general mechanisms that may play
a role in maintaining functional circuit
performance during modulation.
Stability Mechanism #1.Modulators
that Coordinately Act on Opposing
Processes
Harris-Warrick and Johnson (2010)
suggest that the pattern of dopamine
modulation of STG neurons at the cellular
level (Figure 5) is ideally suited to maintain
stable function. Specifically, by acting on
both inward and outward currents, dopa-
mine actions can keep individual neurons,Inc.and therefore the network, within their
operating range (Harris-Warrick and
Johnson, 2010).
Stability Mechanism #2. Voltage
Dependence of Modulator Actions
The importance of the voltage depen-
dence of the NMDA receptor for the
induction of LTP is well appreciated, but
the ability of the NMDA receptor to induce
oscillations in the spinal cord is less well
known (Sigvardt et al., 1985). The neuro-
peptide proctolin elicits a voltage-depen-
dent inward current similar to that evoked
by NMDA (Golowasch and Marder, 1992).
This current is blocked at hyperpolarized
membrane potentials by extracellular
Ca2+ and has a reversal potential about
0mV. Consequently, the peak inward
current activated by proctolin is close to
threshold (Golowasch and Marder, 1992).
Because of its voltage dependence,
the current activated by proctolin in-
creases the amplitude of the oscillations
generated by bursting neurons without
producing a depolarization of the baseline
(Figure 6A). The same effect is seen with
muscarinic agonists such as pilocarpine
or oxotremorine (Marder and Paupardin-
Tritsch, 1978; Swensen and Marder,
2000). In contrast, nicotine, which acti-
vates a conventional nicotinic receptor
(Marder and Eisen, 1984b; Marder and
Paupardin-Tritsch, 1978), depolarizes
the baseline of the oscillator (Figure 6B)
and can result in a depolarization block.
Thus, the voltage dependence of the cur-
rent elicited by proctolin and muscarinic
Figure 6. Effects of Modulatory Substances on a Bursting Pacemaker Neuron
(A) Intracellular recordings from the isolated anterior burster (AB) neuron in control and proctolin. Modified
from Hooper and Marder (1987). Notice the increase in amplitude without change in baseline.
(B) AB neuron in response to nicotine and pilocarpine.
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tains the integrity of the burst generating
mechanism in the pyloric pacemaker
neurons (Marder and Meyrand, 1989).
Stability Mechanism #3.
Convergence of Many Modulators
onto the Same Voltage-Dependent
Current
In addition to proctolin and muscarinic
agonists, a large number of other peptides
including Crustacean Cardioactive Pep-
tide (CCAP), RPCH, TNRNFLRFamide,
SDRNFLRFamide, and Cancer borealis
Tachykin-Related Peptide (CabTRP1a)
activate the same voltage-dependent
current (Swensen and Marder, 2000) and
act on some of the same neurons
(Figure 7A). Because these modulators
converge onto the same current, they
occlude each other’s actions (Figure 7B)
(Swensen and Marder, 2000). Thus, if
a neuron is already highly activated by
one of these modulatory substances,
a second of them will be relatively
ineffective.
Stability Mechanism #4. Saturation
of Postsynaptic Action: Bigger
Synaptic Inputs Do Necessarily
Produce Larger Effects on Target
Neuron Activity
Modulators can enhance the amplitude
of synaptic currents many-fold. Forexample, RPCH produces several-fold
increases in the amplitude of the inhibitory
LP to PD synapse in the pyloric network of
the lobster Homarus americanus (Thiru-
malai et al., 2006). Although this synapse
is the major feedback to the pacemaker
of the pyloric rhythm, this increase in
synaptic strength does not necessarily
change the frequency of the pyloric
rhythm (Thirumalai et al., 2006) because
the effect of the inhibitory input to an
oscillator often saturates as synaptic
strength is increased (Prinz et al.,
2003b). This saturation means that the
network’s activity is de facto protected
against overmodulation of the feedback
synapse to the oscillator.
Stability Mechanism #5.Modulators
Act Coordinately on Multiple
Targets to Keep Systems
Functionally ‘‘Matched’’
In motor systems central pattern gener-
ating networks drive muscles, and it is
the muscle movement that is important
for behavior. Brezina and colleagues
(Brezina et al., 2005, 2000b; Brezina and
Weiss, 2000; Zhurov and Brezina, 2006)
have argued that coordinate modulation
of muscles, neuromuscular junctions,
and the central pattern generating cir-
cuitry ensures that the presynaptic
activity generated in the motor neuronsNeuronis appropriately matched to their muscle
targets. This general principle, of corre-
lated and coordinated modulation of
multiple sites in a sensory-motor circuit
is likely to be a general principle, found
in many nervous systems (Taghert and
Nitabach, 2012).
Can Modulator Action Be Robust
and Predictable Despite Variability
in Underlying Conductances?
Much computational and experimental
evidence shows that there can be consid-
erably variability across animals or across
neurons in the parameters that control
neuronal excitability and network function
even when the circuit output ismaintained
(Calabrese et al., 2011; Goaillard et al.,
2009; Nerbonne et al., 2008; Norris
et al., 2011; Prinz et al., 2004; Roffman
et al., 2012; Schulz et al., 2006, 2007;
Sobie, 2009; Swensen and Bean, 2005;
Tobin et al., 2009). This raises the ques-
tion of whether it is possible for neuromo-
dulation to be reliable across individuals,
if each of them has a nervous system
with different underlying parameters.
The answer to this question is compli-
cated. First, even for modulators that
have robust actions, there can be signifi-
cant differences in the responses of indi-
vidual animals to threshold concentra-
tions (Weimann et al., 1997). Second,
many modulators show state-dependent
actions (Nusbaum and Marder, 1989b;
Szabo et al., 2011), so that the activity or
prior history of activity of the network
determines the extent or sign (Spitzer
et al., 2008) of modulator action. Third,
modulator action may depend critically
on other modulators (Brezina, 2010; Dick-
inson et al., 1997). That said, networks
with different underlying parameters can
respond reliably to the same modulators
(Grashow et al., 2009), although some
may respond anomalously (Grashow
et al., 2009). These data are reminiscent
of what we see in the human population
with pharmacological agents that
produce anomalous responses in a small
subset of people. Thus, although there
are significant individual differences in
circuit structures across individuals, the
particular sets of network parameters
found in the healthy population may be
enriched for sets of parameters that
permit reliable neuromodulatory control
under most conditions.76, October 4, 2012 ª2012 Elsevier Inc. 7
Figure 7. Multiple Modulators Act on the Same Neuron and Converge onto the Same Current
(A) Puff applications of the modulators indicated onto intracellularly recorded LP neuron (Swensen and Marder, 2000).
(B) Voltage-clamp recordings of inward currents evoked by proctolin and CabTRP1a. Top traces, puff of proctolin elicited an inward current. When CabTRP1a
was placed in the bath, eliciting a steady-state inward current, a puff of proctolin produced only a very small additional inward current. Bottom traces, reverse




The discerning among you have already
made the connection between the early
belief that a connectivity diagram would
be sufficient to bring understanding of
how a circuit worked and some of the
more lofty justifications made for the
recent attempts to establish connec-
tomes using anatomical methods (Brigg-
man and Bock, 2012; Briggman and
Denk, 2006; Briggman et al., 2011).
Detailed anatomical data are invaluable.
No circuit can be fully understood without
a connectivity diagram. But the experi-
ence of the small-circuit community
(Bargmann, 2012; Brezina, 2010; Getting,
1989; Jang et al., 2012; Marder and
Bucher, 2007; Marder and Calabrese,
1996) demonstrates unambiguously that
a connectivity diagram is only a necessary
beginning, but not in itself, an answer.
What then is the answer? The full
answer will require a connectivity diagram
that is supplemented with a complete
description of all of the cotransmitters8 Neuron 76, October 4, 2012 ª2012 Elsevierpresent in each neuron. It will require
detailed information about the properties
of the receptors to all of those sub-
stances. It will require having methods
to record simultaneously the electrical
activity of many circuit elements, to
understand circuit dynamics. It will
require systems that allow us to go back
and forth from in vitro and in vivo prepara-
tions. It will require computational models
that will help us to understand how
behavior at one level emerges from the
properties of a lower level.
But most critically, it will require a return
to appreciating the benefits of working on
disparate animal species. Each animal
has devised extraordinary and baroque
circuit mechanisms that employ neuro-
modulation to achieve important behav-
ioral flexibility in the context of its
environment, neuronal complement, and
biomechanical constraints. Many of the
circuit configurations that we will uncover
may be weird and specific solutions to
particular needs of that species. It will
only be by looking for general principlesInc.across species that we will find the more
general rules that govern the robust and
stable neuromodulation needed for func-
tional circuit activity in all animals.ACKNOWLEDGMENTS
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